Disappointment For Novartis As England’s NICE Says No To Migraine Drug Again

Doubts linger over Aimovig's cost effectiveness

 
• By Neena Brizmohun
  
Headache
NICE has denied funding for migraine prevention drug Aimovig • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from United Kingdom

More from Europe